Article thumbnail

Structural and functional alterations of the cell nucleus in skeletal muscle wasting: the evidence in situ

By M. Malatesta and G. Meola

Abstract

The histochemical and ultrastructural analysis of the nuclear components involved in RNA transcription and splicing can reveal the occurrence of cellular dysfunctions eventually related to the onset of a pathological phenotype. In recent years, nuclear histochemistry at light and electron microscopy has increasingly been used to investigate the basic mechanisms of skeletal muscle diseases; the in situ study of nuclei of myofibres and satellite cells proved to be crucial for understanding the pathogenesis of skeletal muscle wasting in sarcopenia, myotonic dystrophy and laminopathies

Topics: Views and Comments
Publisher: PAGEPress Publications
OAI identifier: oai:pubmedcentral.nih.gov:3167325
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. Advanced microscopic and histochemical techniques: diagnostic tools in the molecular era of myology.
  2. Age-related muscle dysfunction.
  3. (1992). An unstable triplet repeat in a gene related to myotonic muscular dystrophy.
  4. Biochemical and immunohistochemical evidence for a non-muscle myosin at the neuromuscular junction in bovine skeletal muscle.
  5. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.
  6. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness.
  7. Demonstration of myosin heavy chain isoforms in rat and humans: the specificity of seven available monoclonal antibodies used in immunohistochemical and immunoblotting methods.
  8. Development of image analysis tool for the classification of muscle fibre type using immunohistochemical staining. Histo -chem
  9. Diagnostic immunohistochemistry in neuromuscular disorders.
  10. Diagnostic immunohistology of muscle diseases.
  11. Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria.
  12. Emerin increase in regenerating muscle fibers.
  13. (1998). Genetic mapping of a second myotonic dystrophy locus.
  14. Hibernation as a far-reaching program for the modulation of RNA transcription.
  15. Increased expression of titin in mouse gastrocnemius muscle in response to an endurance-training program.
  16. Integrins, muscle agrin and sarcoglycans during muscular inactivity conditions: an immunohistochemical study.
  17. (1992). Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’ end of a transcript encoding a protein kinase family member.
  18. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
  19. (1992). Myotonic dystrophy mutation: an unstable CTG repeat in the 3’ untranslated region of the gene.
  20. (2001). Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science
  21. Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies.
  22. Nuclei of aged myofibres undergo structural and functional changes suggesting impairment in RNA processing.
  23. Perichromatin fibrils accumulation in hepatocyte nuclei reveals alterations of pre-mRNA processing during ageing.
  24. Perichromatin fibrils as early markers of transcriptional alterations.
  25. Physical training is associated with changes in NMR and morphometrical parameters of the skeletal muscle in senescent mice.
  26. Pre-mRNA processing is partially impaired in satellite cell nuclei from aged muscles.
  27. Rearrangement of nuclear ribonucleoprotein (RNP)-containing structures during apoptosis and transcriptional arrest.
  28. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.
  29. Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies.
  30. RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study.
  31. Routinely frozen biopsies of human skeletal muscle are suitable for morphological and immunocytochemical analyses at transmission electron microscopy. Eur J Histochem 2010;54:137-42. Views and Comments
  32. Sarcopenia: causes, consequences, and preventions.
  33. Sarcopenia: etiology, clinical consequences, intervention, and assessment.
  34. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly.
  35. Software for muscle fibre type classification and analysis.
  36. Stem cellmediated muscle regeneration and repair in aging and neuromuscular diseases.
  37. The CELF family of RNA binding proteins is implicatViews and Comments[European Journal of Histochemistry 2010; 54:e44] [page 207] ed in cellspecific and developmentally regulated alternative splicing.
  38. The cell nuclei of skeletal muscle cells are transcriptionally active in hibernating edible dormice.
  39. The histochemical profile of the rat extensor digitorum longus muscle differentiates after birth and dedifferentiates in senescence.
  40. The nuclear envelope, human genetic diseases and ageing.
  41. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expandedrepeat transcripts
  42. Ultrastructural cytochemical analyses of nuclear functional architecture.